Search Results for keywords:"April 28, 2025"

The National Institute of Allergy and Infectious Diseases is having a meeting on April 28, 2025, which will be closed to the public. The meeting will involve reviewing and evaluating grant applications which may include confidential trade secrets and personal information. This meeting will take place via video conference, and the contact person for more information is Vishakha Sharma, Ph.D. from the National Institutes of Health.

The Food and Drug Administration (FDA) has delayed the effective date of the rule defining the term "healthy" on food labels from February 25, 2025, to April 28, 2025, following a presidential memorandum on regulatory freeze. The rule updates how and when the term "healthy" can be used to help consumers identify nutritious foods according to current dietary guidelines. This delay allows for additional review, and although the rule's compliance date isn't until 2028, companies can start following it before then if they choose.

The National Institute of Diabetes and Digestive and Kidney Diseases has announced a closed meeting to discuss certain grant applications, which will be held on April 28, 2025, from 1:00 p.m. to 2:30 p.m. The meeting will be conducted virtually and is closed to the public to protect confidential information related to trade secrets and personal data of individuals involved in the applications. The committee will evaluate and review grant applications related to Hematology RC2. Interested parties can contact Dr. Lan Tian for more information.

The National Institute of Diabetes and Digestive and Kidney Diseases is holding a special meeting to discuss grant applications. This meeting is scheduled for April 28, 2025, from 11:00 a.m. to 1:30 p.m., and it will be conducted virtually. The meeting will be closed to the public because it may involve sensitive information such as trade secrets and personal details. For questions, people can contact Ann A. Jerkins, Ph.D., the Scientific Review Officer.